PCI-24781, ≥98%

Catalog No. 821737

General Information

Synonyms	CRA-024781
CAS No.	783355-60-2
M.F.	C₂₁H₂₃N₃O₅
M.W.	397.42

Technical Data

Appearance	Off-white powder
Assay	≥98%
Solubility	DMSO
Storage	-20℃
Description	A novel broad spectrum HDAC inhibitor targeting HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 and HDAC10. A Phase I study of PCI-24781 in subjects with lymphoma is currently ongoing.

Reference

Park JM, et al. PLoS One. 2013 May 28;8(5):e65369
Kitamura T, et al. J Hepatol. 2012 Jul;57(1):84-91
Bantscheff M, et al. Nat Biotechnol. 2011 Mar;29(3):255-65
Yang C, et al. Anticancer Res. 2011 Apr;31(4):1115-23
Singh MM, et al. Neuro Oncol. 2011 Aug;13(8):894-903
Yang C, et al. Cancer Chemother Pharmacol. 2011 Feb;67(2):439-46

Size	Price	Quantity	Favorites
5 mg	USD95
50 mg	USD570

Please inquire for non-standard packs and bulk quantities.

Availability: Ships in 1-3 days

For research use only. Not for human use.

> Certificate of Analysis

> MSDS

	(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject	821737, PCI-24781, ≥98%, 783355-60-2
*Message
*Code

PCI-24781, ≥98%

Inquire